Hospital Orkli, LLC

Saint Petersburg 199178

0 studies enrolling now · 4 studies all time

What they study most

Castration-resistant Prostate Cancer, Metastatic Renal Cell Carcinoma, Non-muscle Invasive Bladder Cancer, Prostate Cancer Metastatic, Renal Cell Carcinoma, Urothelial Cancer

Studies at this site

• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Stopped early
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early